Women who have close family members with endocrine diseases, including type 2 diabetes, thyroid diseases and polycystic ovary syndrome (PCOS), are at higher risk of pregnancy loss, a new study has ...
Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have identified a mechanism that protects the female brain from genetic diseases. Although one of the two X chromosomes is ...
A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...
Patients with prostate cancer consider clinical trial options significantly earlier in their journey compared to patients with other solid tumors. This is an ASCO Meeting Abstract from the 2024 ASCO ...
(Beyond Pesticides, September 9, 2021) A new study published in Toxicology Reports finds the same chemicals that disrupt the endocrine (hormone) system also disrupt the nervous system. Endocrine ...
Wendy Wisner is a journalist and international board certified lactation consultant (IBCLC). She has written about all things pregnancy, maternal/child health, parenting, and general health and ...
WALTHAM, Mass. & ANN ARBOR, Mich.--(BUSINESS WIRE)--OvaScience SM (Nasdaq:OVAS) and privately-held Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel ...
LEBANON, N.J.--(BUSINESS WIRE)--Recordati Rare Diseases announces that positive results from the Phase III LINC-4 study of Isturisa® have been presented at the Endocrine Society’s annual meeting.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results